Profil
Troy Lister currently works at American Chemical Society, as Member.
Dr. Lister also formerly worked at Spero Therapeutics, Inc., as Senior Vice President-Research & Development from 2014 to 2022 and Verve Therapeutics, Inc., as Chief Scientific Officer from 2024 to 2025.
Dr. Lister received his undergraduate degree and doctorate degree from Flinders University.
Postes actifs de Troy Lister
| Sociétés | Poste | Début |
|---|---|---|
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Corporate Officer/Principal | - |
Anciens postes connus de Troy Lister
| Sociétés | Poste | Fin |
|---|---|---|
| VERE THER | Directeur Technique/Scientifique/R&D | 25/07/2025 |
| SPERO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/05/2022 |
Formation de Troy Lister
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Commercial Services |
Flinders University
Flinders University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Verve Therapeutics, Inc.
Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
















